Austin, C. D., Gonzalez Edick, M., Ferrando, R. E., Solon, M., Baca, M., Mesh, K., Bradding, P., Gauvreau, G. M., Sumino, K., FitzGerald, J. M., Israel, E., Bjermer, L., Bourdin, A., Arron, J. R., Choy, D. F., Olsson, J. K., Abreu, F., Howard, M., Wong, K., Cai, F., Peng, K., Putnam, W. S., Holweg, C. T., Matthews, J. G., Kraft, M., Woodruff, P. G., & , (2020). a randomized, placebo‐controlled trial evaluating effects of lebrikizumab on airway eosinophilic inflammation and remodelling in uncontrolled asthma (CLAVIER). Clinical & experimental allergy, 50(12), 1342–1351. http://access.bl.uk/ark:/81055/vdc_100115142545.0x000045